Seres Therapeutics, Inc. (MCRB)
5.28
-0.28
(-5.04%)
USD |
NASDAQ |
Sep 09, 16:00
5.28
0.00 (0.00%)
After-Hours: 17:10
Seres Therapeutics Market Cap : 51.89M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 54.64M |
| September 04, 2026 | 56.21M |
| September 03, 2026 | 55.43M |
| September 02, 2026 | 54.44M |
| September 01, 2026 | 50.91M |
| August 31, 2026 | 48.25M |
| August 28, 2026 | 50.22M |
| August 27, 2026 | 48.65M |
| August 26, 2026 | 46.78M |
| August 25, 2026 | 49.14M |
| August 24, 2026 | 45.80M |
| August 21, 2026 | 44.81M |
| August 20, 2026 | 44.91M |
| August 19, 2026 | 45.99M |
| August 18, 2026 | 42.65M |
| August 17, 2026 | 44.32M |
| August 14, 2026 | 44.62M |
| August 13, 2026 | 44.03M |
| August 12, 2026 | 46.39M |
| August 11, 2026 | 45.60M |
| August 10, 2026 | 49.14M |
| August 07, 2026 | 47.86M |
| August 06, 2026 | 47.37M |
| August 05, 2026 | 49.19M |
| August 04, 2026 | 51.59M |
| Date | Value |
|---|---|
| August 03, 2026 | 49.43M |
| July 31, 2026 | 46.33M |
| July 30, 2026 | 45.85M |
| July 29, 2026 | 44.60M |
| July 28, 2026 | 46.04M |
| July 27, 2026 | 46.52M |
| July 24, 2026 | 47.63M |
| July 23, 2026 | 50.17M |
| July 22, 2026 | 50.65M |
| July 21, 2026 | 50.36M |
| July 20, 2026 | 49.02M |
| July 17, 2026 | 51.13M |
| July 16, 2026 | 49.69M |
| July 15, 2026 | 52.28M |
| July 14, 2026 | 51.17M |
| July 13, 2026 | 53.91M |
| July 10, 2026 | 58.61M |
| July 09, 2026 | 64.65M |
| July 08, 2026 | 68.49M |
| July 07, 2026 | 78.08M |
| July 06, 2026 | 73.96M |
| July 02, 2026 | 74.24M |
| July 01, 2026 | 76.16M |
| June 30, 2026 | 75.68M |
| June 29, 2026 | 74.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 292.77M |
| Amgen, Inc. | 211.48B |
| Anika Therapeutics, Inc. | 279.57M |
| BioCryst Pharmaceuticals, Inc. | 2.248B |
| Imunon, Inc. | 7.092M |
Market Cap Related Metrics
| PS Ratio | 26.40 |
| PEG Ratio | -0.0104 |
| Price to Book Value | 1.503 |
| Price | 5.28 |
| Earnings Yield | -43.13% |
| PEGY Ratio | -0.0104 |